New potential anti-cancer compounds discovered by the Stagljar lab
In the latest issue of Nature Chemical Biology, the Stagljar lab used the mammalian membrane two-hybrid drug screening (MaMTH-DS), a technique that they previously pioneered, to identify new compounds that inhibit the activity of oncoproteins that cause breast cancer. In this case they found four compounds that inhibit the dimerization of the epidermal growth factor receptor (EGFR), which is commonly mutated in non-small-cell lung cancers that have become […]